Pay in 4 interest-free payments of $5.56 Learn more
Ships within 48 hours · Estimated delivery Nov 6 - Nov 11
The FDA subsequently classified AOD-9604 within Category 2 of the bulk drug substance review process, and the compound was later withdrawn from that nomination in April 2026
Where the difference matters mechanistically (e.g., for any claim involving copper delivery into a target cell), it matters quite a lot
Initially, ischemia causes ATP depletion, anaerobic metabolism, and intracellular acidosis, resulting in impaired ion pumps and calcium overload 1,2,3
Copper tripeptide-3 increases dermal cell proliferation and viability while increasing the deposition of collagen to renew the extracellular matrix
HCC cells have been observed to induce CTL (cytotoxic T lymphocyte) dysfunction via the Gln-GLS2-ERS pathway
